TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
SANA

Sana Biotechnology Inc

Healthcare · Biotechnology · —

3.00$ -3.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SANA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +1,109.3% +75.9% +54.7% -27.2% -31.3% -11.4% -16.8%
– +342.6% +166.5% +45.2% -20.4% -52.0% -24.7% -7.5%
– +161.3% +55.9% +102.7% -30.1% -24.5% -4.5% -43.7%
– +353.7% +172.2% +45.7% -23.1% -51.6% -25.7% -9.3%
– +11,662.1% +59.8% -40.5% +2.2% – – –
– – +0.0% +0.0% +0.0% +0.0% +0.0% +0.0%
– – +0.0% +0.0% +0.0% +0.0% +0.0% +0.0%
– +1,073.7% +106.5% -65.2% -19.3% -14.1% -9.8% +2.2%
– +982.5% +62.8% +215.5% +12.4% -42.2% -29.5% +73.3%
– – +176.6% +146.7% +35.3% +6.5% -5.0% +19.2%
– -100.0% – -1.5% +28.8% +43.8% +26.8% -68.0%
– – – – -31.5% -42.4% -12.9% -35.8%
– – – – – – – –
– +0.0% +0.1% -11.2% +13.2% +3.3% +18.7% +9.7%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?